HEADER TRANSFERASE 06-DEC-06 2O5K
TITLE CRYSTAL STRUCTURE OF GSK3BETA IN COMPLEX WITH A BENZOIMIDAZOL
TITLE 2 INHIBITOR
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: GLYCOGEN SYNTHASE KINASE-3 BETA;
COMPND 3 CHAIN: A;
COMPND 4 FRAGMENT: RESIDUES 22-393;
COMPND 5 SYNONYM: GSK-3 BETA;
COMPND 6 EC: 2.7.11.26;
COMPND 7 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21;
SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693;
SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21;
SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 9 EXPRESSION_SYSTEM_PLASMID: MODIFIED PET21B
KEYWDS GSK3BETA, BENZOIMIDAZOL INHIBITOR, TRANSFERASE
EXPDTA X-RAY DIFFRACTION
AUTHOR D.SHIN,S.C.LEE,Y.S.HEO,Y.S.CHO,Y.E.KIM,Y.L.HYUN,J.M.CHO,Y.S.LEE,S.RO
REVDAT 3 25-OCT-23 2O5K 1 REMARK SEQADV
REVDAT 2 24-FEB-09 2O5K 1 VERSN
REVDAT 1 23-OCT-07 2O5K 0
JRNL AUTH D.SHIN,S.C.LEE,Y.S.HEO,W.Y.LEE,Y.S.CHO,Y.E.KIM,Y.L.HYUN,
JRNL AUTH 2 J.M.CHO,Y.S.LEE,S.RO
JRNL TITL DESIGN AND SYNTHESIS OF 7-HYDROXY-1H-BENZOIMIDAZOLE
JRNL TITL 2 DERIVATIVES AS NOVEL INHIBITORS OF GLYCOGEN SYNTHASE
JRNL TITL 3 KINASE-3BETA
JRNL REF BIOORG.MED.CHEM.LETT. V. 17 5686 2007
JRNL REFN ISSN 0960-894X
JRNL PMID 17764934
JRNL DOI 10.1016/J.BMCL.2007.07.056
REMARK 2
REMARK 2 RESOLUTION. 3.20 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : CNS 1.1
REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-
REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,
REMARK 3 : READ,RICE,SIMONSON,WARREN
REMARK 3
REMARK 3 REFINEMENT TARGET : ENGH & HUBER
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.20
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.53
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 680379.700
REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 89.5
REMARK 3 NUMBER OF REFLECTIONS : 6574
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING SET) : 0.240
REMARK 3 FREE R VALUE : 0.309
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.100
REMARK 3 FREE R VALUE TEST SET COUNT : 207
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.021
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 6
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.20
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.40
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 88.30
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1023
REMARK 3 BIN R VALUE (WORKING SET) : 0.2680
REMARK 3 BIN FREE R VALUE : 0.2990
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 2.90
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 31
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.054
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2790
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 34
REMARK 3 SOLVENT ATOMS : 0
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 14.50
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 43.30
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -20.82000
REMARK 3 B22 (A**2) : 16.01000
REMARK 3 B33 (A**2) : 4.81000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.35
REMARK 3 ESD FROM SIGMAA (A) : 0.44
REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.46
REMARK 3 ESD FROM C-V SIGMAA (A) : 0.54
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.009
REMARK 3 BOND ANGLES (DEGREES) : 1.400
REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.40
REMARK 3 IMPROPER ANGLES (DEGREES) : 0.950
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : OVERALL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELING.
REMARK 3 METHOD USED : FLAT MODEL
REMARK 3 KSOL : 0.42
REMARK 3 BSOL : 98.57
REMARK 3
REMARK 3 NCS MODEL : NULL
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM
REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM
REMARK 3 PARAMETER FILE 3 : HBI.PARAM
REMARK 3 PARAMETER FILE 4 : ION.PARAM
REMARK 3 PARAMETER FILE 5 : NULL
REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP
REMARK 3 TOPOLOGY FILE 2 : WATER.TOP
REMARK 3 TOPOLOGY FILE 3 : HBI.TOP
REMARK 3 TOPOLOGY FILE 4 : ION.TOP
REMARK 3 TOPOLOGY FILE 5 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: THE STRUCTURE WAS REFINED ALSO WITH
REMARK 3 REFMAC 5.0.
REMARK 4
REMARK 4 2O5K COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 15-DEC-06.
REMARK 100 THE DEPOSITION ID IS D_1000040714.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 25-JAN-05
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 7.5
REMARK 200 NUMBER OF CRYSTALS USED : NULL
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : N
REMARK 200 RADIATION SOURCE : ROTATING ANODE
REMARK 200 BEAMLINE : NULL
REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU300
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.54
REMARK 200 MONOCHROMATOR : DOUBLE MIRROR
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : IMAGE PLATE
REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK
REMARK 200 DATA SCALING SOFTWARE : D*TREK
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 6785
REMARK 200 RESOLUTION RANGE HIGH (A) : 3.200
REMARK 200 RESOLUTION RANGE LOW (A) : 30.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 92.2
REMARK 200 DATA REDUNDANCY : 5.200
REMARK 200 R MERGE (I) : 0.09200
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.8000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.20
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.40
REMARK 200 COMPLETENESS FOR SHELL (%) : 79.0
REMARK 200 DATA REDUNDANCY IN SHELL : 2.20
REMARK 200 R MERGE FOR SHELL (I) : 0.39000
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.100
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: AMORE
REMARK 200 STARTING MODEL: 1R0E
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 50.63
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.49
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M HEPES NA, 0.1M PROLINE, 20%
REMARK 280 PEG3350, PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 35.47000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 40.89750
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.31600
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 40.89750
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 35.47000
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.31600
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 MET A 22
REMARK 465 HIS A 23
REMARK 465 HIS A 24
REMARK 465 HIS A 25
REMARK 465 HIS A 26
REMARK 465 HIS A 27
REMARK 465 HIS A 28
REMARK 465 SER A 29
REMARK 465 ARG A 30
REMARK 465 ASP A 31
REMARK 465 LYS A 32
REMARK 465 ASP A 33
REMARK 465 GLY A 34
REMARK 465 GLN A 385
REMARK 465 ALA A 386
REMARK 465 ALA A 387
REMARK 465 ALA A 388
REMARK 465 SER A 389
REMARK 465 THR A 390
REMARK 465 PRO A 391
REMARK 465 THR A 392
REMARK 465 ASN A 393
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 ASP A 90 CB CG OD1 OD2
REMARK 470 ARG A 92 CG CD NE CZ NH1 NH2
REMARK 470 LYS A 292 CG CD CE NZ
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 PRO A 300 C - N - CA ANGL. DEV. = 10.7 DEGREES
REMARK 500 PRO A 380 C - N - CA ANGL. DEV. = 10.3 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 PRO A 44 104.92 -52.06
REMARK 500 PRO A 48 -133.55 -82.91
REMARK 500 ASP A 58 -6.16 72.86
REMARK 500 THR A 59 119.50 -23.43
REMARK 500 ILE A 62 -3.37 -142.08
REMARK 500 SER A 66 -51.04 -20.32
REMARK 500 CYS A 76 -17.13 -48.46
REMARK 500 ASP A 77 -83.52 -95.07
REMARK 500 ASP A 90 -31.40 -35.91
REMARK 500 LYS A 91 -53.00 66.37
REMARK 500 LEU A 104 155.46 -40.55
REMARK 500 ASP A 105 70.28 177.04
REMARK 500 CYS A 107 -4.51 -57.21
REMARK 500 VAL A 110 128.13 -29.24
REMARK 500 GLU A 121 -147.74 -178.36
REMARK 500 LYS A 122 -114.53 57.70
REMARK 500 ASP A 124 65.06 66.60
REMARK 500 PRO A 136 -112.41 -77.48
REMARK 500 GLU A 137 -171.55 -44.92
REMARK 500 ALA A 149 18.45 -145.06
REMARK 500 LYS A 150 23.90 41.69
REMARK 500 GLN A 151 -156.13 -114.86
REMARK 500 TYR A 171 -73.38 -72.13
REMARK 500 ASP A 181 24.99 179.06
REMARK 500 LEU A 187 75.09 -104.17
REMARK 500 ASP A 192 8.08 -66.88
REMARK 500 ASP A 200 85.31 54.97
REMARK 500 VAL A 214 -97.84 -49.95
REMARK 500 SER A 215 -64.53 -160.69
REMARK 500 TYR A 216 126.00 -34.63
REMARK 500 ILE A 217 -156.16 170.93
REMARK 500 CYS A 218 -152.36 30.47
REMARK 500 ARG A 220 -80.34 -59.58
REMARK 500 ALA A 231 -167.45 -75.85
REMARK 500 THR A 232 -10.15 -171.35
REMARK 500 LEU A 252 -22.07 -144.02
REMARK 500 GLN A 254 146.52 177.07
REMARK 500 PHE A 257 75.06 -118.41
REMARK 500 PRO A 258 -133.09 -53.27
REMARK 500 VAL A 272 -68.55 -104.46
REMARK 500 ASN A 285 -46.16 102.50
REMARK 500 PRO A 286 139.74 -26.14
REMARK 500 TYR A 288 61.93 -65.38
REMARK 500 LYS A 292 80.67 -172.80
REMARK 500 PRO A 294 95.79 -35.68
REMARK 500 PRO A 300 139.41 -21.17
REMARK 500 PRO A 307 -10.82 -48.27
REMARK 500 THR A 326 21.31 -72.94
REMARK 500 SER A 338 -28.52 -37.81
REMARK 500 VAL A 348 97.54 -66.57
REMARK 500
REMARK 500 THIS ENTRY HAS 57 RAMACHANDRAN OUTLIERS.
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HBM A 0
DBREF 2O5K A 29 393 UNP P49841 GSK3B_HUMAN 29 393
SEQADV 2O5K MET A 22 UNP P49841 EXPRESSION TAG
SEQADV 2O5K HIS A 23 UNP P49841 EXPRESSION TAG
SEQADV 2O5K HIS A 24 UNP P49841 EXPRESSION TAG
SEQADV 2O5K HIS A 25 UNP P49841 EXPRESSION TAG
SEQADV 2O5K HIS A 26 UNP P49841 EXPRESSION TAG
SEQADV 2O5K HIS A 27 UNP P49841 EXPRESSION TAG
SEQADV 2O5K HIS A 28 UNP P49841 EXPRESSION TAG
SEQRES 1 A 372 MET HIS HIS HIS HIS HIS HIS SER ARG ASP LYS ASP GLY
SEQRES 2 A 372 SER LYS VAL THR THR VAL VAL ALA THR PRO GLY GLN GLY
SEQRES 3 A 372 PRO ASP ARG PRO GLN GLU VAL SER TYR THR ASP THR LYS
SEQRES 4 A 372 VAL ILE GLY ASN GLY SER PHE GLY VAL VAL TYR GLN ALA
SEQRES 5 A 372 LYS LEU CYS ASP SER GLY GLU LEU VAL ALA ILE LYS LYS
SEQRES 6 A 372 VAL LEU GLN ASP LYS ARG PHE LYS ASN ARG GLU LEU GLN
SEQRES 7 A 372 ILE MET ARG LYS LEU ASP HIS CYS ASN ILE VAL ARG LEU
SEQRES 8 A 372 ARG TYR PHE PHE TYR SER SER GLY GLU LYS LYS ASP GLU
SEQRES 9 A 372 VAL TYR LEU ASN LEU VAL LEU ASP TYR VAL PRO GLU THR
SEQRES 10 A 372 VAL TYR ARG VAL ALA ARG HIS TYR SER ARG ALA LYS GLN
SEQRES 11 A 372 THR LEU PRO VAL ILE TYR VAL LYS LEU TYR MET TYR GLN
SEQRES 12 A 372 LEU PHE ARG SER LEU ALA TYR ILE HIS SER PHE GLY ILE
SEQRES 13 A 372 CYS HIS ARG ASP ILE LYS PRO GLN ASN LEU LEU LEU ASP
SEQRES 14 A 372 PRO ASP THR ALA VAL LEU LYS LEU CYS ASP PHE GLY SER
SEQRES 15 A 372 ALA LYS GLN LEU VAL ARG GLY GLU PRO ASN VAL SER TYR
SEQRES 16 A 372 ILE CYS SER ARG TYR TYR ARG ALA PRO GLU LEU ILE PHE
SEQRES 17 A 372 GLY ALA THR ASP TYR THR SER SER ILE ASP VAL TRP SER
SEQRES 18 A 372 ALA GLY CYS VAL LEU ALA GLU LEU LEU LEU GLY GLN PRO
SEQRES 19 A 372 ILE PHE PRO GLY ASP SER GLY VAL ASP GLN LEU VAL GLU
SEQRES 20 A 372 ILE ILE LYS VAL LEU GLY THR PRO THR ARG GLU GLN ILE
SEQRES 21 A 372 ARG GLU MET ASN PRO ASN TYR THR GLU PHE LYS PHE PRO
SEQRES 22 A 372 GLN ILE LYS ALA HIS PRO TRP THR LYS VAL PHE ARG PRO
SEQRES 23 A 372 ARG THR PRO PRO GLU ALA ILE ALA LEU CYS SER ARG LEU
SEQRES 24 A 372 LEU GLU TYR THR PRO THR ALA ARG LEU THR PRO LEU GLU
SEQRES 25 A 372 ALA CYS ALA HIS SER PHE PHE ASP GLU LEU ARG ASP PRO
SEQRES 26 A 372 ASN VAL LYS LEU PRO ASN GLY ARG ASP THR PRO ALA LEU
SEQRES 27 A 372 PHE ASN PHE THR THR GLN GLU LEU SER SER ASN PRO PRO
SEQRES 28 A 372 LEU ALA THR ILE LEU ILE PRO PRO HIS ALA ARG ILE GLN
SEQRES 29 A 372 ALA ALA ALA SER THR PRO THR ASN
HET HBM A 0 34
HETNAM HBM 2-(2,4-DICHLORO-PHENYL)-7-HYDROXY-1H-BENZOIMIDAZOLE-4-
HETNAM 2 HBM CARBOXYLIC ACID [2-(4-METHANESULFONYLAMINO-PHENYL)-
HETNAM 3 HBM ETHYL]-AMIDE
HETSYN HBM 2-(2,4-DICHLOROPHENYL)-4-HYDROXY-N-(2-{4-
HETSYN 2 HBM [(METHYLSULFONYL)AMINO]PHENYL}ETHYL)-1H-BENZIMIDAZOLE-
HETSYN 3 HBM 7-CARBOXAMIDE
FORMUL 2 HBM C23 H20 CL2 N4 O4 S
HELIX 1 1 ASN A 95 LEU A 104 1 10
HELIX 2 2 THR A 138 SER A 147 1 10
HELIX 3 3 ARG A 148 LYS A 150 5 3
HELIX 4 4 PRO A 154 PHE A 175 1 22
HELIX 5 5 LYS A 183 GLN A 185 5 3
HELIX 6 6 ALA A 224 PHE A 229 1 6
HELIX 7 7 SER A 236 LEU A 250 1 15
HELIX 8 8 SER A 261 GLY A 274 1 14
HELIX 9 9 THR A 277 MET A 284 1 8
HELIX 10 10 PRO A 300 PHE A 305 1 6
HELIX 11 11 PRO A 310 ARG A 319 1 10
HELIX 12 12 THR A 324 ARG A 328 5 5
HELIX 13 13 THR A 330 ALA A 336 1 7
HELIX 14 14 HIS A 337 PHE A 339 5 3
HELIX 15 15 PHE A 340 ASP A 345 1 6
HELIX 16 16 THR A 363 SER A 368 1 6
HELIX 17 17 ASN A 370 PRO A 372 5 3
HELIX 18 18 LEU A 373 ILE A 378 1 6
SHEET 1 A 6 THR A 38 ALA A 42 0
SHEET 2 A 6 GLN A 52 VAL A 61 -1 O VAL A 54 N VAL A 40
SHEET 3 A 6 TYR A 71 LEU A 75 -1 O LYS A 74 N THR A 57
SHEET 4 A 6 LEU A 81 GLN A 89 -1 O ILE A 84 N TYR A 71
SHEET 5 A 6 VAL A 126 ASP A 133 -1 O VAL A 126 N GLN A 89
SHEET 6 A 6 LEU A 112 SER A 118 -1 N SER A 118 O TYR A 127
SHEET 1 B 2 ILE A 177 CYS A 178 0
SHEET 2 B 2 LYS A 205 GLN A 206 -1 O LYS A 205 N CYS A 178
SHEET 1 C 2 LEU A 187 LEU A 189 0
SHEET 2 C 2 LEU A 196 LEU A 198 -1 O LYS A 197 N LEU A 188
SITE 1 AC1 13 ILE A 62 ALA A 83 ASP A 133 TYR A 134
SITE 2 AC1 13 VAL A 135 PRO A 136 TYR A 140 ARG A 141
SITE 3 AC1 13 GLN A 185 ASN A 186 LEU A 188 ASP A 200
SITE 4 AC1 13 ARG A 220
CRYST1 70.940 72.632 81.795 90.00 90.00 90.00 P 21 21 21 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.014096 0.000000 0.000000 0.00000
SCALE2 0.000000 0.013768 0.000000 0.00000
SCALE3 0.000000 0.000000 0.012226 0.00000